When a child under the age of seven is diagnosed with Type 1 diabetes, the story is often more urgent, more dramatic and more difficult to manage than when older kids—or adults—first receive the diagnosis. A new study helps explain why : it turns out that the architecture of insulin-producing cells in the pancreas of very young children leaves them much more vulnerable to rapid disease progression. ( Medical Xpress ) What’s going on inside the pancreas? In a normal, healthy p

Diabetes during pregnancy is rising around the world—and new global guidance is here to help. In honor of World Diabetes Day, the World Health Organization (WHO) released comprehensive guidelines designed to improve screening, diagnosis, and treatment for both gestational diabetes and pre-existing diabetes in pregnancy. Source:  WHO – https://www.who.int/news/item/14-11-2025-who-launches-global-guidelines-on-diabetes-during-pregnancy-on-world-diabetes-day Why These New Guidel

Mark your calendars!  On Friday, November 14, 2025 , the Diabetes Network of Arizona  is bringing the community together for an evening of fun, food, and friendship  at one of the Valley’s most unique venues— Chicken N’ Pickle  in Glendale. Whether you’re living with diabetes, supporting someone who is, or simply passionate about health and wellness, this event is the perfect way to celebrate World Diabetes Day  while connecting with others who understand the journey. 🗓 Even

For the first time in years, obesity rates in the U.S. are showing a slight decline — but the latest health data brings mixed news. While fewer Americans are classified as obese, diabetes rates have climbed to a record high, signaling that the fight against metabolic disease is far from over. According to new data from the Centers for Disease Control and Prevention (CDC), about 41.1% of U.S. adults were considered obese in 2023 , a small but meaningful drop from 42% in 2022.

For decades, type 2 diabetes was seen as a lifelong condition—something you could manage, but not reverse. Now, a new study from Italy suggests that diabetes remission may actually be possible  for some people using a class of medications known as GLP-1 receptor agonists . What the Study Found Researchers from the University of Palermo  tracked more than 500 adults with type 2 diabetes who were treated with GLP-1 medications alongside lifestyle changes. The results were inter

Scripps Professor Luc Teyton If you live with Type 1 diabetes or know someone who does, you know how relentless it can be — constant glucose checks, insulin doses, and worrying about highs and lows. But some exciting new research out of Scripps Research in California  could one day change how doctors understand (and maybe even prevent) the disease altogether. The Big News A Scripps professor named Luc Teyton  just won a $3.2 million federal grant  to dig into one of the bigge